Comera Life Sciences Holdings, Inc. Business Combination, Contingent Consideration, Liability, Measurement Input
Comera Life Sciences Holdings, Inc. had Business Combination, Contingent Consideration, Liability, Measurement Input of 991.00% as of 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput · last filed 2023-03-17
- 2022-12-31: Business Combination, Contingent Consideration, Liability, Measurement Input 991.00%.
- 2022-09-30: Business Combination, Contingent Consideration, Liability, Measurement Input 991.00%.
- 2022-06-30: Business Combination, Contingent Consideration, Liability, Measurement Input 991.00%.
| Period end | Business Combination, Contingent Consideration, Liability, Measurement Input |
|---|---|
| 2022-12-31 | 991.00% 10-K · filed 2023-03-17 |
| 2022-09-30 | 991.00% 10-Q · filed 2022-11-14 |
| 2022-06-30 | 991.00% 10-Q · filed 2022-08-15 |